Markets

BrilliA Inc (BRIA) filed its 2025 annual report on Form 20-F with the SEC. The report details the company’s performance in the intimate apparel market and is accessible via the SEC website and BrilliA’s investor relations portal. BrilliA, a global provider of end-to-end solutions for intimate apparel brands, manages sourcing, design, and supply chain for clients like Fruit of the Loom and H&M. The press release includes forward-looking statements subject to risks detailed in the company’s SEC filings.

ByteDance launched Seed LiveInterpret 2.0, an end-to-end simultaneous interpretation model excelling in Chinese-English translation. It offers ultra-low latency (2-3 seconds) and accuracy rivaling human interpreters, exceeding 70% in complex scenarios and 80% in single-person speeches. Key features include zero-shot voice cloning and intelligent balancing of translation quality, latency, and speech cadence. Evaluations show it surpasses other systems, marking a significant advancement in AI translation.

A report indicates a 72.2% drop in DeepSeek’s monthly downloads in Q2 2025. However, this decline is attributed to DeepSeek’s integration into third-party platforms and its focus on open-source LLM development for AGI advancement. Users are being diverted through these channels, impacting direct app downloads. While specialized AI tools like “AI+office” and “AI+education” platforms are gaining traction, DeepSeek remains a key AI player, despite facing challenges like delayed updates and user experience concerns.

Karman Space & Defense (KRMN) announced the pricing of a public offering of 21 million shares at $49 per share, offered by existing stockholders. Underwriters, led by Citigroup and Evercore ISI, have a 30-day option to purchase an additional 3.15 million shares. Karman will not receive any proceeds from the offering, which is expected to close on July 25th, 2025. The SEC approved the registration statement on July 23, 2025. Karman provides critical systems for the space and defense industries.

Julian LeFay, a key figure behind *The Elder Scrolls* franchise, has died at 59 after a battle with cancer. His studio, OnceLost Games, announced his passing shortly after he retired to spend time with family. LeFay was the lead engineer on *Arena* and *Daggerfall*, shaping the series’ core mechanics. He later co-founded OnceLost Games, developing *The Wayward Realms*. Bethesda’s Todd Howard expressed deep sorrow, acknowledging LeFay’s vital role in building the studio.

At the 2025 OpenAtom conference, Huawei’s Zhang Xiaofeng highlighted OpenHarmony’s progress in community growth (over 9,000 contributors), technological advancements, and industry adoption with over 1,200 compatible products. OpenHarmony supports diverse sectors, from finance to transportation. Customized OS distributions like “YiHong” are driving digital transformation. Integration of HarmonyOS in government and enterprise office applications is accelerating, promoting efficient office experiences. Zhang Xiaofeng called for increased collaboration to build a thriving OpenHarmony ecosystem.

Neuralink, Elon Musk’s brain-computer interface company, plans a major expansion, aiming to implant BCI chips in 20,000 patients annually by 2031, generating $1 billion in revenue. The company intends to establish five clinics in six years, developing “Telepathy,” “Blindsight,” and “Deep” implants for communication, vision restoration, and neurological disorder treatment. US approval for “Telepathy” is expected by 2029, with “Blindsight” launching in 2030. Neuralink, valued at $9 billion, has secured $1.3 billion in funding.

Tharimmune (THAR) announced a $1.74 million registered direct offering consisting of common stock and warrants. Units are priced at $1.786, including one share or pre-funded warrant and a common warrant. President Street Global is the placement agent. Proceeds will fund working capital and general corporate purposes. The offering is expected to close around July 25, 2025. This funding aims to support Tharimmune’s work in immunology and inflammation therapies, including their clinical asset, TH104.

China’s Ministry of Public Security is increasing oversight of ADAS technologies amid growing adoption. New regulations and stricter scrutiny of automakers’ marketing claims are expected. The focus is on enhanced automaker accountability, refined legal frameworks for Level 0-2 ADAS, and public awareness campaigns emphasizing driver responsibility. Authorities will collaborate to clarify “human-machine co-driving” definitions and safety standards. The core message is that drivers are responsible for vehicle safety as current systems are not fully autonomous, and “hands-off, eyes-off” behavior carries risks.

Nutex Health Inc. (NASDAQ: NUTX) is defending itself against allegations made in a recent short seller report questioning its revenue collection process. The company maintains its billing practices are sound and disputes the report’s claims, calling them misleading and based on a misunderstanding of its business model. Nutex Health operates 24 micro-hospitals and outpatient departments across 11 states. Further details will be provided in the upcoming earnings release and Form 10-Q filing, due on or before August 14, 2025.